Could a COVID shot boost cancer treatment? new study investigates

NCT ID NCT07341321

Not yet recruiting Knowledge-focused Sponsor: Medical University of Graz Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether getting an mRNA COVID-19 vaccine within three months before starting immunotherapy improves outcomes for people with liver cancer. Researchers will review medical records of 200 patients in Austria to compare response rates, survival, and side effects between vaccinated and unvaccinated groups. The goal is to see if the vaccine might help the immune system fight cancer better when combined with checkpoint inhibitors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mRNA COVID-19 vaccine
What this could lead to: If it works, this could suggest that getting a COVID-19 vaccine before starting immune therapy may help liver cancer patients respond better to treatment.
What could go wrong: This is a retrospective study, meaning it looks back at existing data, not a controlled experiment. Results may show correlation, not causation, and could be influenced by other factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHECKPOINT INHIBITOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHECKPOINT INHIBITOR HEPATOCELLULAR CARCINOMA MRNA VACCINATION

Contacts and locations

Locations

Klinikum Wels-Grieskirchen

Wels, Austria
Krankenhaus der Barmherzigen Brüder St Veit an der Glan

Sankt Veit an der Glan, Austria
Medical University of Graz

Graz, 8010, Austria
Ordensklinikum Linz

Linz, Austria
University Hospital St. Pölten

Sankt Pölten, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.